Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.30
Delayed Data
As of 4:02pm ET
 -0.02 / -1.52%
Today’s Change
0.75
Today|||52-Week Range
2.50
-2.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues2.1M2.9M4.0M4.3M
 
 
 
 
 
Cost of Goods Sold299.2K183.4K442.1K487.7K
 
 
 
 
 
Depreciation And Amortization149.8K149.3K132.2K140.1K
 
 
 
 
 
 
Operating ExpensesGross Income1.7M2.5M3.4M3.7M
 
 
 
 
 
General Expenses8.1M6.4M7.7M6.3M
 
 
 
 
 
Research And Development4.0M2.3M3.9M2.6M
 
 
 
 
 
Total Operating Expenses8.5M6.8M8.3M6.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.4M-3.9M-4.3M-2.6M
 
 
 
 
 
Extraordinary Credit1.7M100.0K0.001.1M
 
 
 
 
Extraordinary Charge-1.4M-4.3M-1.6M0.00
 
 
 
 
Pre-Tax Equity Earnings-262.2K-6.2K-26.8K-10.0K
 
 
 
 
 
Interest Expense On Debt966.6K1.6M2.1M2.2M
 
 
 
 
 
Other Expenses26.5K-4.8K4.4K708.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-9.7M-8.1M-3.7M
 
 
 
 
 
Income Taxes0.000.000.00-436.1K
 
 
Minority Interest-100.00-241.00-340.00-174.00
 
 
 
 
 
Preferred Dividend-46.0K0.000.000.00
 
 
Discontinued Operations0.000.000.00758.6K
 
 
Net Income-7.3M-9.7M-8.1M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS149.8M150.1M150.2M154.6M
 
 
 
 
 
Shares To Calculate EPS Diluted149.8M150.1M150.2M154.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.06-$0.05-$0.02
 
 
 
 
 
EPS Diluted-$0.05-$0.06-$0.05-$0.02